Examinando por Autor "Poulter, Neil R."
Mostrando 1 - 3 de 3
Resultados por página
Opciones de clasificación
- PublicaciónAcceso abiertoMay Measurement Month 2017(ESC - European Society of Cardiology, 2019-04-01) Lopez-Jaramillo, Patricio; Otero, Johanna; Rueda-Quijano, Sandra Milena; Camacho López, Paul Anthony; Rey, Juan José; Sánchez, Gregorio; Narváez, Claudia; Accini, José Luis; Arcos, Edgar; García, Henry; Pérez, Maritza; Aroca, Gustavo; Beaney, Thomas; Kobeissi, Elsa; Poulter, Neil R.; MasiraDespite the availability of efficient methods to evaluate blood pressure (BP) and of safe and efficient medication to treat and control hypertension, the levels of awareness, treatment and control are very low globally, particularly in low- and middle-income countries. To highlight the importance of improving these rates, the International Society of Hypertension (ISH) endorsed by the World Hypertension League have implemented the May Measurement Month initiative. We present here the results obtained in Colombia. The Fundación Oftalmológica de Santander (FOSCAL) led the implementation of this strategy in Colombia and 11 departments participated. The data collection followed the guidelines of the ISH. The information collected was compiled for the report generation and the submission to the Technical Secretariat of the ISH. Data cleaning was performed locally by FOSCAL. Data were collated and analysed centrally. A total of 22 258 participants (58.8% female) were included in the analysis. Mean age was 40.9 ± 17.7 years. Age and sex-standardized BP excluding participants receiving BP medications was 118/74.3 mmHg, and in those on treatment 125/78 mmHg. High BP was present in 5036 (22.8%) individuals, 1637 of 18 644 (8.8%) who were not receiving anti-hypertensive medications were hypertensive, and 961 of 3359 (28.6%) receiving treatment were not controlled. These results highlight the need to develop innovative promotion strategies at individual and population levels to increase the awareness of the importance of BP, and the consequences of not having well-controlled hypertension. This initiative is an effective and easy to implement strategy that should be maintained in the coming years.
- PublicaciónAcceso abiertoMay measurement month 2017. Latin America(Wolters Kluwer Health, 2020-06-01) Barbosa, Eduardo C.D.; Ramirez, Agustin; Beaney, Thomas; Kobeissi, Elsa; Lopez-Jaramillo, Patricio; Hernánez-Hernández, Rafael; Eibel, Bruna; Lanas, Fernando; Penaherrera, Ernesto; Marini, Marcos; Boggia, José; Ortellado, Jose; Gomez, Enrique; Sánchez, Enrique; Bryce, Alfonso; Valdez, Osiris; Beistline, Holly; Nwokocha, Chukwuemeka; Connell, Kenneth; Barrientos, Ana; Wyss, Fernando; Kenerson, John; Poulter, Neil R.; EverestObjectives: To raise awareness of blood pressure, measured by number of countries involved, number of people screened, and number of people who have untreated or inadequately treated hypertension. Methods: An opportunistic cross-sectional survey of volunteers aged at least 18 years was carried out in May 2017. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard May measurement month protocol. Eighteen countries in Latin America and the Caribbean participated in the campaign, providing us with a wide sample for characterization. Results: During May measurement month 2017 in Latin America and the Caribbean, 105 246 individuals were screened. Participants who had cardiovascular disease, 2245 (2.3%) had a prior myocardial infarction, and 1711 (1.6%) a previous stroke, additionally 6760 (6.4%) individuals were diabetic, 7014 (6.7%) current smokers and 9262 (8.8%) reported alcohol intake once or more per week. Mean SBP was 122.7 mmHg and DBP was 75.6 mmHg. After imputation, 42 328 participants (40,4%) were found to be hypertensive. Conclusion: The high numbers of participants detected with hypertension and the relatively large proportion of participants on antihypertensive treatment but with uncontrolled hypertension reinforces the importance of this annual event in our continent, to raise awareness of the prevention of cardiovascular events.
- PublicaciónAcceso abiertoMay Measurement Month 2018. An analysis of blood pressure screening results from Colombia(European Society of Cardiology, 2020-08-28) Lopez-Jaramillo, Patricio; Otero, Johanna; Alvernia, Juliana; Ney-Salazar, Daniela; Lopez-Lopez, Jose; Accini, Jose Luis; Aroca, Gustavo; Urina-Triana, Miguel; Sánchez-Vallejo, Gregorio; Arcos, Edgar; Casanova, María E.; García, Henry; Beaney, Thomas; Ster, Anca Chis; Poulter, Neil R.; MasiraHigh blood pressure (BP) is the leading global preventable cause of death and the most common risk factor for cardiovascular disease (CVD). However, due to its asymptomatic nature, the lack of awareness of this condition causes underdiagnosis and low rates of adherence to pharmacological treatment. Looking for practical approaches to increase awareness worldwide, the International Society of Hypertension (ISH) implemented the 2nd May Measurement Month campaign in 2018 (MMM18). In order to contribute to this initiative, Colombia participated as one of the 89 countries involved in this hypertension screening programme. Blood pressure was measured in subjects from 11 departments in Colombia. Under the leadership of the Fundación Oftalmológica de Santander (FOSCAL), 400 volunteers across the country collected the data following the MMM protocol. Measurements from 35 548 participants with a mean age of 41.9 years were obtained. In total, 9475 (26.7%) of the total population studied had hypertension. Of those with hypertension, 69.9% of these subjects were aware of their condition, 65.0% were on antihypertensive medication, and 43.1% had controlled BP. Of those on medication, 66.3% had controlled BP. Hypertension screening, awareness, treatment, and control should be a priority in public health objectives due to its elevated burden of disease and direct association with increased CVD. The MMM campaign provided a positive impact in the diagnosis of hypertension across Colombia. Although efforts are being made to expand treatment capability and adherence, still more are needed to insure a broader coverage of antihypertensive medication in Colombia.